Chad Vanderbilt, Assistant Member and Pathologist at Memorial Sloan Kettering Cancer Center, shared on LinkedIn:
“AI at Scale for Clinical Impact (ASCI) Workshop Accepted Paper Announcement:
36 accepted papers. Ten talks. Twenty-six posters.
The full program for ASCI, a NeurIPS 2026 workshop, is now live.
Archived manuscripts will be posted in the Proceedings of Machine Learning Research on the day of the conference.
Congratulations to everyone whose work was accepted! The work in this field is progressing so quickly.
Thank you to the authors who submitted and to the program committee. The quality of submissions was impressive and all of the spotlights are pushing the state-of-the-art in this field.
We are looking forward to the talks and posters in Sydney.
Keynotes and Invited Speakers: Thomas Fuchs, Hoifung Poon, Piotr Bojanowski, Jorge Reis-Filho, Jana Lipkova, Ruijiang Li, Jakob Nikolas Kather, Bo Wang, Nigam Shah, Danielle Bitterman
Organizers: Chad Vanderbilt, Neeraj Kumar, Gabriele Campanella, Ruchika Verma, Jia Wu, Rukhmini Roy Muhammad Waqas Sheikh, H.R. Tizhoosh, Saghir Alfasly, Wataru Uegami, Kostas Triaridis, Joel Saltz, Katherine Hoadley, Ali Kamali, Siddharth Singi, Greg Goldgof.”
You can also read: Artificial Intelligence in Cancer Immunotherapy
